Table 4.
Variables | N (%) | Pa |
---|---|---|
Age, years | ||
< 55 (n = 13) | 6 (46) | 0.70 |
≥ 55 (n = 11) | 4 (36) | |
Gender | ||
Male (n = 13) | 4 (31) | 0.41 |
Female (n = 11) | 6 (54) | |
Disease status at transplantation | ||
Early (n = 13) | 5 (38) | 1.00 |
Non-early (n = 11) | 5 (45) | |
Preconditioning | ||
MAC (n = 15) | 7 (47) | 0.68 |
RIC (n = 9) | 3 (33) | |
TBI | ||
≤ 8 Gy (n = 15) | 6 (40) | 1.00 |
> 8 Gy (n = 9) | 4 (44) | |
Acute GVHD | ||
< Grade II (n = 14) | 5 (36) | 0.68 |
≥ Grade II (n = 10) | 5 (50) | |
HHV-6B reactivation | ||
Not higher-level reactivation (n = 9) | 1 (11) | 0.033 |
Higher-level reactivation (n = 15) | 9 (60) |
MAC myeloablative conditioning, RIC reduced-intensity conditioning, TBI total body irradiation, GVHD graft-versus-host disease, HHV-6B human herpesvirus 6B
a Fisher’s exact test